Kexiang Yan
9PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 12, 2026
TYK2 and IL-23 Pathway Therapies in Psoriasis: Associations With IL-6, Tryptophan Metabolism, and Depressive Symptoms.Lanmei Lin, Canbin Dong, Gujie Wu
|Dec 11, 2022
Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis.Fuxin Zhang, Ling Han, Bing Wang
|Nov 11, 2022
B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis.Wenjing Yang, Qiong Huang, Ling Han
|Jun 06, 2022
iTRAQ-based quantitative proteomics reveals biomarkers/pathways in psoriasis that can predict the efficacy of methotrexate.K X Yan, Q Meng, H He
|Jun 06, 2022
A preliminary study of peripheral T-cell subsets in porokeratosis patients with MVK or MVD variants.L Tao, Y K Huang, K X Yan
|Jul 26, 2021
A Genome-wide association study identified HLA-C associated with the effectiveness of methotrexate for psoriasis treatment.Y Zhang, X Ding, Z Meng
Pageof 2
